Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…

OMER Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Omeros Insider Trading History Chart

Omeros Share Price & Price History

^$6.75

▼ -0.2 (-2.88%)

As of 11/15/2024 01:00 AM ET

Days: 30 | 90 | 365

“Amazon Coin” set to outperform Bitcoin

From True Market Insiders | Ad

#1 FREE Crypto for 2024

Omeros Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/17/2023	Gregory A. Demopulos	CEO	Buy	15,000	$1.68	$25,200.00	123,945
11/15/2023	Peter A Md Demopulos	Director	Buy	10,000	$1.53	$15,300.00	208,516
5/22/2023	Arnold C. Hanish	Director	Sell	5,000	$6.46	$32,300.00	35,067

Bill Gates’ is about to mint millionaires (again) with Stargate.

From Brownstone Research | Ad

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

SEC Filings (Institutional Ownership Changes) for Omeros (NASDAQ:OMER)

48.79% of Omeros stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Omeros Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	1,339,251	$5.32M	0.0%	+0.5%	2.311%
11/15/2024	Barclays PLC	94,640	$0.38M	0.0%	+121.3%	0.163%
11/15/2024	MML Investors Services LLC	18,600	$74K	0.0%	+19.2%	0.032%
11/15/2024	Jane Street Group LLC	58,277	$0.23M	0.0%	+15.9%	0.101%
11/15/2024	Wellington Management Group LLP	76,945	$0.31M	0.0%	N/A	0.133%
11/15/2024	State Street Corp	1,226,053	$4.87M	0.0%	+0.3%	2.116%
11/15/2024	Stifel Financial Corp	1,904,207	$7.56M	0.0%	+0.1%	3.286%
11/15/2024	HighTower Advisors LLC	59,339	$0.24M	0.0%	+7.2%	0.102%
11/13/2024	Townsquare Capital LLC	12,383	$49K	0.0%	-34.3%	0.021%
11/13/2024	BNP Paribas Financial Markets	12,388	$49K	0.0%	+130.6%	0.021%
11/12/2024	Charles Schwab Investment Management Inc.	485,035	$1.93M	0.0%	+4.0%	0.837%
11/6/2024	Oppenheimer & Co. Inc.	18,602	$74K	0.0%	-70.2%	0.032%
10/16/2024	SPC Financial Inc.	19,400	$77K	0.0%	N/A	0.033%
10/3/2024	SG Americas Securities LLC	20,104	$80K	0.0%	N/A	0.035%
8/19/2024	B. Riley Wealth Advisors Inc.	11,305	$46K	0.0%	-26.5%	0.020%
8/15/2024	The Manufacturers Life Insurance Company	22,433	$91K	0.0%	-10.8%	0.039%
8/15/2024	AQR Capital Management LLC	25,800	$0.11M	0.0%	N/A	0.045%
8/12/2024	Hsbc Holdings PLC	10,427	$41K	0.0%	-29.2%	0.018%
8/1/2024	Rhumbline Advisers	111,778	$0.45M	0.0%	+6.1%	0.193%
7/26/2024	Bank of New York Mellon Corp	218,580	$0.89M	0.0%	+16.6%	0.377%
7/25/2024	Cypress Capital Group	35,000	$0.14M	0.0%	+40.0%	0.060%
5/20/2024	Virtu Financial LLC	10,091	$35K	0.0%	-65.3%	0.017%
5/17/2024	Comerica Bank	30,000	$0.10M	0.0%	+20.0%	0.052%
5/10/2024	Vanguard Group Inc.	3,250,284	$11.21M	0.0%	+2.6%	5.610%
5/7/2024	Susquehanna Fundamental Investments LLC	155,957	$0.54M	0.0%	N/A	0.269%
5/7/2024	Oppenheimer & Co. Inc.	24,503	$85K	0.0%	N/A	0.042%
5/7/2024	SG Americas Securities LLC	12,315	$42K	0.0%	-59.5%	0.021%
5/1/2024	BNP Paribas Financial Markets	30,102	$0.10M	0.0%	+75.5%	0.052%
3/27/2024	Nomura Holdings Inc.	383,144	$1.25M	0.0%	-14.0%	0.609%
2/13/2024	Tower Research Capital LLC TRC	8,069	$26K	0.0%	+199.9%	0.013%
2/12/2024	Stifel Financial Corp	1,890,674	$6.18M	0.0%	-6.8%	3.007%
2/9/2024	Hohimer Wealth Management LLC	22,530	$74K	0.0%	-57.1%	0.036%
2/9/2024	Corient Private Wealth LLC	663,663	$2.17M	0.0%	-3.4%	1.056%
2/9/2024	Coldstream Capital Management Inc.	28,130	$92K	0.0%	+42.1%	0.045%
2/6/2024	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	30,000	$98K	0.0%	+200.0%	0.048%
2/5/2024	Brighton Jones LLC	33,516	$0.11M	0.0%	-29.5%	0.053%
1/26/2024	Cerity Partners LLC	21,850	$71K	0.0%	N/A	0.035%
1/24/2024	Rocky Mountain Advisers LLC	26,800	$88K	0.0%	-20.0%	0.043%
1/16/2024	Raymond James & Associates	10,925	$36K	0.0%	-75.4%	0.017%
1/12/2024	SG Americas Securities LLC	30,438	$100K	0.0%	+59.3%	0.048%
11/14/2023	Ancora Advisors LLC	210,023	$0.61M	0.0%	+23.1%	0.334%
11/14/2023	Nomura Holdings Inc.	445,482	$1.30M	0.0%	-28.3%	0.709%
11/13/2023	Stifel Financial Corp	2,027,917	$5.92M	0.0%	-1.4%	3.226%
11/7/2023	Barclays PLC	45,629	$0.13M	0.0%	+51.2%	0.073%
11/1/2023	Jacob Asset Management of New York LLC	55,168	$0.16M	0.2%	-31.2%	0.088%
10/13/2023	SG Americas Securities LLC	19,105	$56K	0.0%	N/A	0.030%
9/21/2023	Barclays PLC	30,173	$0.16M	0.0%	-62.5%	0.048%
9/12/2023	Farther Finance Advisors LLC	6,000	$33K	0.0%	N/A	0.010%
8/10/2023	Jacob Asset Management of New York LLC	80,168	$0.44M	0.5%	-16.6%	0.128%
8/10/2023	Cetera Advisors LLC	88,365	$0.48M	0.0%	N/A	0.141%
8/4/2023	American International Group Inc.	29,302	$0.16M	0.0%	N/A	0.047%
8/2/2023	Bank of Montreal Can	563,297	$3.40M	0.0%	N/A	0.897%
7/25/2023	Raymond James & Associates	44,718	$0.24M	0.0%	-25.2%	0.071%
7/13/2023	Cambridge Investment Research Advisors Inc.	47,430	$0.26M	0.0%	-13.1%	0.075%
7/6/2023	Apella Capital LLC	14,288	$78K	0.0%	N/A	0.023%
5/11/2023	Jacob Asset Management of New York LLC	96,168	$0.45M	0.5%	+11.6%	0.153%
5/8/2023	Brighton Jones LLC	54,517	$0.25M	0.0%	-12.5%	0.087%
5/4/2023	Barclays PLC	80,406	$0.37M	0.0%	+167.5%	0.128%
5/4/2023	Cypress Capital Group	50,000	$0.23M	0.0%	-9.1%	0.080%
5/1/2023	Sheaff Brock Investment Advisors LLC	60,125	$0.28M	0.0%	-4.8%	0.096%
4/14/2023	Raymond James & Associates	59,818	$0.28M	0.0%	-58.5%	0.095%
2/8/2023	Cambridge Investment Research Advisors Inc.	55,087	$0.12M	0.0%	+46.9%	0.088%
2/1/2023	Bank of Montreal Can	563,095	$1.53M	0.0%	-0.7%	0.898%
2/1/2023	Hohimer Wealth Management LLC	52,530	$0.12M	0.0%	+33.7%	0.084%
1/27/2023	Denver Wealth Management Inc.	46,581	$0.11M	0.1%	N/A	0.074%
1/10/2023	Coldstream Capital Management Inc.	17,795	$40K	0.0%	N/A	0.028%
11/14/2022	Cubist Systematic Strategies LLC	204,122	$0.64M	0.0%	+806.0%	0.325%
11/10/2022	UBS Group AG	652,743	$2.06M	0.0%	-3.3%	1.041%
11/9/2022	Brighton Jones LLC	53,540	$0.17M	0.0%	+233.7%	0.085%
11/4/2022	Cypress Capital Group	45,000	$0.14M	0.0%	-39.2%	0.072%
11/3/2022	Sonora Investment Management Group LLC	10,375	$29K	0.0%	-99.8%	0.017%
10/27/2022	Lesa Sroufe & Co	17,735	$56K	0.1%	N/A	0.028%
10/26/2022	Belvedere Trading LLC	54,136	$0.19M	0.0%	-27.9%	0.086%
10/25/2022	Raymond James & Associates	103,518	$0.33M	0.0%	-34.9%	0.165%
8/15/2022	Laurion Capital Management LP	17,897	$49K	0.0%	N/A	0.029%
8/13/2022	Ronald Blue Trust Inc.	5,000	$30K	0.0%	N/A	0.008%
8/11/2022	Denver Wealth Management Inc.	41,671	$0.12M	0.1%	N/A	0.066%
8/4/2022	Brighton Jones LLC	16,042	$44K	0.0%	-58.9%	0.026%
8/3/2022	DDD Partners LLC	11,131	$31K	0.0%	N/A	0.018%
8/2/2022	Sheaff Brock Investment Advisors LLC	57,580	$0.16M	0.0%	+16.1%	0.092%
8/2/2022	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	10,000	$28K	0.0%	N/A	0.016%
7/26/2022	Cypress Capital Group	74,000	$0.20M	0.0%	+100.0%	0.118%
7/13/2022	Cambridge Investment Research Advisors Inc.	37,487	$0.10M	0.0%	+33.7%	0.060%
5/12/2022	Jacob Asset Management of New York LLC	114,910	$0.69M	0.4%	-30.7%	0.183%
5/11/2022	Roanoke Asset Management Corp NY	12,000	$72K	0.0%	N/A	0.019%
5/6/2022	Quad Cities Investment Group LLC	10,200	$61K	0.0%	N/A	0.016%
5/3/2022	Hohimer Wealth Management LLC	39,280	$0.24M	0.0%	-20.3%	0.063%
5/2/2022	National Asset Management Inc.	15,568	$94K	0.0%	-17.2%	0.025%
2/14/2022	Opti Capital Management LP	6,100,000	$5.60M	0.4%	-53.8%	9.753%
2/14/2022	GSA Capital Partners LLP	45,308	$0.29M	0.0%	-29.0%	0.072%
2/11/2022	Ensign Peak Advisors Inc	19,360	$0.12M	0.0%	N/A	0.031%
2/10/2022	Rafferty Asset Management LLC	16,149	$0.10M	0.0%	N/A	0.026%
2/10/2022	Teacher Retirement System of Texas	11,412	$73K	0.0%	N/A	0.018%
2/9/2022	Principal Financial Group Inc.	10,255	$66K	0.0%	-58.8%	0.016%
2/9/2022	BNP Paribas Arbitrage SA	146,011	$0.94M	0.0%	+1,254.1%	0.233%
2/9/2022	Jacob Asset Management of New York LLC	165,923	$1.07M	0.5%	-49.4%	0.265%
2/9/2022	Rocky Mountain Advisers LLC	36,405	$0.23M	0.3%	+68.3%	0.058%
2/9/2022	Baird Financial Group Inc.	27,100	$0.17M	0.0%	+68.3%	0.043%
2/8/2022	Raymond James Financial Services Advisors Inc.	14,068	$90K	0.0%	N/A	0.022%
2/8/2022	Bank of America Corp DE	324,931	$2.09M	0.0%	+110.9%	0.520%

Data available starting January 2016

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases, including complement-mediated diseases, cancers, and addictive and compulsive disorders. The company's products under development include Narsoplimab (OMS721/MASP-2) that has completed pivotal trial for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); that is in Phase III clinical trial for the treatment of immunoglobulin A nephropathy (IgAN); and Phase II clinical trial to treat COVID-19. It also develops OMS1029 that is in phase I clinical trials for long-acting second-generation antibody targeting lectin pathway disorders; OMS906 that has completed phase II clinical trials for Paroxysmal nocturnal hemoglobinuria, complement 3 glomerulopathy, and other alternative pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; and Adoptive T-Cell and Chimeric Antigen Receptor (CAR) T-Cell Therapies and Immunomodulators/Immunotoxins/Cancer Vaccines for the treatment of various cancers. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.

Today's Range

Now: $6.75

$6.52

$7.15

50 Day Range

MA: $4.14

$3.54

$6.95

52 Week Range

Now: $6.75

$1.38

$7.51

Volume

1,945,100 shs

Average Volume

466,168 shs

Market Capitalization

$391.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47

Who are the company insiders with the largest holdings of Omeros?: Omeros' top insider shareholders include:
Peter A Md Demopulos (Director)
Gregory A Md Demopulos (CEO)
Arnold C Hanish (Director)
Learn More about top insider investors at Omeros.
Who are the major institutional investors of Omeros?: Omeros' top institutional investors include:
Stifel Financial Corp — 3.29%
Geode Capital Management LLC — 2.31%
State Street Corp — 2.12%
Charles Schwab Investment Management Inc. — 0.84%
Verition Fund Management LLC — 0.00%
Barclays PLC — 0.16%
Learn More about top institutional investors of Omeros stock.
Which institutional investors are selling Omeros stock?: Within the last quarter, OMER stock was sold by these institutional investors:
Oppenheimer & Co. Inc.
Townsquare Capital LLC
Which institutional investors are buying Omeros stock?: Within the previous quarter, OMER stock was purchased by institutional investors including:
Wellington Management Group LLP
Verition Fund Management LLC
Barclays PLC
SG Americas Securities LLC
SPC Financial Inc.
Charles Schwab Investment Management Inc.
Wolverine Trading LLC
Jane Street Group LLC
In the previous year, these company insiders have bought Omeros stock:
Peter A Md Demopulos (Director)
Gregory A Md Demopulos (CEO)
Learn More investors buying Omeros stock.